These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 2140991

  • 21. Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro.
    Hodges LC, Bergerson JS, Hunter DS, Walker CL.
    Toxicol Sci; 2000 Apr; 54(2):355-64. PubMed ID: 10774817
    [Abstract] [Full Text] [Related]

  • 22. Rapid reduction of uterine leiomyomas with monthly injections of D-Trp6-GnRH.
    van Leusden HA, Dogterom AA.
    Gynecol Endocrinol; 1988 Mar; 2(1):45-51. PubMed ID: 2972173
    [Abstract] [Full Text] [Related]

  • 23. Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens.
    Pasqualini JR, Gelly C, Nguyen BL.
    Ann N Y Acad Sci; 1990 Mar; 595():106-16. PubMed ID: 2375600
    [Abstract] [Full Text] [Related]

  • 24. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
    Levens E, Luo X, Ding L, Williams RS, Chegini N.
    Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
    [Abstract] [Full Text] [Related]

  • 25. Immunoreactive and estrogen-binding estrogen receptors, and progestin receptor levels in uterine leiomyomata and their parental myometrium.
    Chrapusta S, Konopka B, Paszko Z, Sieinski W, Szamborski J.
    Eur J Gynaecol Oncol; 1990 Jul; 11(4):275-81. PubMed ID: 2245811
    [Abstract] [Full Text] [Related]

  • 26. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
    Néri C, Blangy D, Schatz B, Drieu K, Berebbi M, Martin PM.
    Cancer Res; 1990 Sep 15; 50(18):5892-7. PubMed ID: 2168284
    [Abstract] [Full Text] [Related]

  • 27. Gonadotropin-releasing hormone effects on placental hormones during gestation: II. Progesterone, estrone, estradiol and estriol.
    Siler-Khodr TM, Khodr GS, Valenzuela G, Rhode J.
    Biol Reprod; 1986 Mar 15; 34(2):255-64. PubMed ID: 3513854
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fibrocystic disease of the breast in premenopausal women: histohormonal correlation and response to luteinizing hormone releasing hormone analog treatment.
    Monsonego J, Destable MD, De Saint Florent G, Amouroux J, Kouyoundjian JC, Haour F, Breau JL, Israel L, Comaru-Schally AM, Schally AV.
    Am J Obstet Gynecol; 1991 May 15; 164(5 Pt 1):1181-9. PubMed ID: 1852100
    [Abstract] [Full Text] [Related]

  • 30. [GnRH-analogs in the therapy of uterine myomatosis].
    Wieacker P, Geisthövel F, Adelberger V, Breckwoldt M.
    Ther Umsch; 1990 Dec 15; 47(12):951-7. PubMed ID: 2151405
    [Abstract] [Full Text] [Related]

  • 31. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy.
    Nisolle M, Gillerot S, Casanas-Roux F, Squifflet J, Berliere M, Donnez J.
    Hum Reprod; 1999 Nov 15; 14(11):2844-50. PubMed ID: 10548634
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR, Marshburn PB, Weatherall PT, Bradshaw KD, Breslau NA, Byrd W, Roark M, Steinkampf MP.
    J Clin Endocrinol Metab; 1993 May 15; 76(5):1217-23. PubMed ID: 8496313
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
    Vu K, Greenspan DL, Wu TC, Zacur HA, Kurman RJ.
    Hum Pathol; 1998 Apr 15; 29(4):359-63. PubMed ID: 9563785
    [Abstract] [Full Text] [Related]

  • 39. Estrogen and progesterone binding proteins in normal human myometrium and leiomyoma tissue.
    Pollow K, Geilfuss J, Boquoi E, Pollow B.
    J Clin Chem Clin Biochem; 1978 Sep 15; 16(9):503-11. PubMed ID: 712341
    [Abstract] [Full Text] [Related]

  • 40. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.
    Cheng YM, Chou CY, Huang SC, Lin HC.
    BJOG; 2001 Jan 15; 108(1):95-102. PubMed ID: 11213012
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.